Doron Nevo - Hadasit Bio External Director
HDST Stock | 88.00 6.30 7.17% |
Director
Mr. Doron Nevo was appointed External Director at HBL Hadasit BioHoldings Ltd effective July 29, 2018. His work experience includes the following roles Chief Executive Officer at Kilolambada Technologies and Director at AudioCodes Ltd and Ultra Charge Limited. He holds a BS degree in Electrical Engineering from The Technion Israel Institute of Technology and a MS degree in Telecommunications Management from Polytechnic University in New York. since 2018.
Age | 61 |
Tenure | 6 years |
Professional Marks | MBA |
Phone | 972 2 677 8757 |
Web | https://www.hbl.co.il |
Hadasit Bio Management Efficiency
The company has return on total asset (ROA) of (0.0296) % which means that it has lost $0.0296 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4387) %, meaning that it generated substantial loss on money invested by shareholders. Hadasit Bio's management efficiency ratios could be used to measure how well Hadasit Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Moriah Katriel | Computer Direct | 55 | |
Yaacov Goldman | Meitav Dash Investments | 62 | |
Maayan Gaitelband | Skyline Investments | 42 | |
Daniel Leventhal | Skyline Investments | 47 | |
Riki Granot | One Software Technologies | 48 | |
Yacov Elinav | Meitav Dash Investments | ||
Ron Ettlinger | Magic Software Enterprises | 52 | |
Amir Tamari | Skyline Investments | 52 | |
Ilan Grinboim | Meitav Dash Investments | 52 | |
Yehezkel Zeira | Magic Software Enterprises | 72 | |
Rivka Granot | One Software Technologies | 50 | |
Ronit Noam | Meitav Dash Investments | 46 | |
Jonathan Assia | Meitav Dash Investments | 34 | |
Moshe Vidman | Alrov Properties Lodgings | 70 | |
Ronnie BarOn | Alrov Properties Lodgings | 68 | |
Eitan Raff | Alrov Properties Lodgings | 76 | |
Shmuel Hauser | Alrov Properties Lodgings | 62 | |
Ronen Harel | One Software Technologies | 54 | |
Neil Labatte | Skyline Investments | 56 | |
Eli Niv | Alrov Properties Lodgings | 60 | |
Lana Sherman | Skyline Investments | 47 |
Management Performance
Return On Equity | -0.44 | |||
Return On Asset | -0.0296 |
Hadasit Bio Leadership Team
Elected by the shareholders, the Hadasit Bio's board of directors comprises two types of representatives: Hadasit Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hadasit. The board's role is to monitor Hadasit Bio's management team and ensure that shareholders' interests are well served. Hadasit Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hadasit Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yaakov Naparstek, Director | ||
Yigal Erlich, Director | ||
Oren Levy, Sr Director | ||
Rob Fink, IR Contact Officer | ||
Merav Kaye, Director | ||
Michal Sapir, External Director | ||
Baruch Halpert, Chairman of the Board | ||
Alejandro Igelman, VP Fin | ||
Doron Cohen, Internal Auditor | ||
Michel Habib, CEO | ||
Asaf Reisfeld, Director | ||
Yoram Azulay, Vice President - Finance | ||
Doron Nevo, External Director | ||
Ophir Shahaf, CEO | ||
Yaron Kulas, External Director | ||
Ehud Kokia, Director | ||
Einat Zisman, Director | ||
Moise Habib, CEO | ||
Tamar Raz, Director | ||
Elka Nir, External Director | ||
Erez Meltzer, Director | ||
Yoram Azulai, VP CFO |
Hadasit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hadasit Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.44 | |||
Return On Asset | -0.0296 | |||
Operating Margin | 0.08 % | |||
Current Valuation | (3.4 M) | |||
Shares Outstanding | 11.09 M | |||
Shares Owned By Insiders | 74.99 % | |||
Price To Book | 0.52 X | |||
Price To Sales | 0.90 X | |||
Gross Profit | 35.09 M | |||
EBITDA | 28.67 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hadasit Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hadasit Bio's short interest history, or implied volatility extrapolated from Hadasit Bio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |